000			01936nam a2200229Ia 4500
003			NULRC
005			20250520102958.0
008			250520s9999 xx 000 0 und d
020			_a044307240X
040			_cNULRC
050			_aRS 100 .P43 2004
245		0	_aPharmacoeconomics / _cedited by Tom Walley, Alan Haycox and Angela Boland
260			_aLondon, United Kingdom : _bChurchill Livingstone, _cc2004
300			_axii, 203 pages : _billustrations ; _c23 cm.
365			_bUSD6.65
504			_aIncludes index.
505			_a1.Basics of economics, health economics and pharmacoeconomics -- 2.The economics of healthcare and healthcare systems -- 3.The public policy context for pharmacoeconomics -- 4.Pharmacoeconomics: an industry perspective -- 5.Disease management and the technique of programme budgeting and marginal analysis -- 6.Cost of illness studies -- 7.Approaches to pharmacoeconomic analysis -- 8.Pharmacoeconomics and clinical trials -- 9.Modelling in health economics -- 10.Quality assurance in pharmacoeconomic analyses -- 11.The future challenges.
520			_aThis introductory textbook of pharmacoeconomics is ideal for all those working in, aspiring to work in or interested in the pharmaceutical industry. It assumes no prior knowledge of this subject but is written at a level appropriate, for example, for those studying for a postgraduate degree or diploma in pharmaceutical medicine and who already have a first degree in science or medicine. The book emphasizes how pharmacoeconomics can be of assistance in "real world" decision making, covers the development of insuring, financing and delivery of health care in the developed world and the increasing role of governments and explains the trend towards the critical scrutiny of health service activity.
650			_aDRUGS -- COST EFFECTIVENESS
700			_aWalley, Tom;Haycox, Alan;Boland, Angela _eeditor;editor;editor
942			_2lcc _cBK
999			_c20431 _d20431